Skip to content

Apotheek Hulsbosch

Active
Private limited companyfounded 2006active for 20 yearsMichielsplein 15, 3930 Hamont-Achel, BelgiumKBO/BCE: BE 0879.969.548

From the official registers: KBO 20 annual accounts at the National Bank publications in the Belgian Official Gazette

Summary

Apotheek Hulsbosch has been active since 2006 and the Belgian Official Gazette contains no insolvency or warning signals. The 2026 annual accounts show equity of €6.8m and a net result of €1.9m. Equity is growing by about 17% per year across the filed financial years. Its solvency ranks better than 61% of 351 sector peers (NACE 47, financial year 2026). The computed 12-month bankruptcy probability is 0.2% (very low).

Risk analysisFollow ReportCompare
Apotheek HulsboschActiveChecked score 91/100
Risk analysis ReportCompare

Overview

Official details

KBO
Status
Active since 14-03-2006 Normal situation
Legal form
Private limited company
Registered office
Michielsplein 15, 3930 Hamont-Achel
Activity
Retail sale of pharmaceutical products NACE 47730and 2 others
Establishment units
3 establishment units
Financial year end
31 March
Peppol
Reachable since 04-12-2025
Company details

Who decides

Board
Holdings
Shares in 4 companies including Apotheek Hulsbosch Kristien and APOTHEEK MEES HAMONT
Board & ownership

How it is doing

91 Excellent Checked score 2026
Bankruptcy probabilitywithin 12 months
0.2%
Annual accounts to 31-03-2026
Turnover
€11.6m
Profit
€1.9m
▲ 27.5%
Equity
€6.8m
▲ 25.8%
Total assets
€14.4m
▲ 9.0%
Staff
16.7 FTE
▲ 32.5%
2026 accounts 66 days early
Filed on 26-08-2026at the National Bank
Financials
Why 91raises riskLiquidity: current ratio 0.43, cash €759,495lowers riskFounded in 2006Profit of €1.9m (financial year 2026)Equity €6.8m (47.1% of total assets)Show the evidence

Checked score

Score 2026
91 / 100
Excellent
Probability in this band: under 0.55%
Financially better than 71% of its sector peers (NACE 47, small)
Every signal that counts is listed under Signals.
Financial strength · tick = 2025
Strong
Solvency 72+6
equity 47.1% of total assets
Liquidity 38+2
short-term debt 39.7% · cash 5.3%
Profitability 90+7
return on assets 13.4%
Bankruptcy probability, 12 months
0.2% Very low
0%0.5%1.5%4%10%≥ 25%

About 2 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median 0.4% (3,694 companies, NACE 47, small)
Last 24 months 11-2024: 0.8%highest value 12-2024: 0.2%▼ -0.6 percentage points vs 11-2024 01-2025: 0.2%● unchanged vs 12-2024 02-2025: 0.2%● unchanged vs 01-2025 03-2025: 0.2%● unchanged vs 02-2025 04-2025: 0.2%● unchanged vs 03-2025 05-2025: 0.2%● unchanged vs 04-2025 06-2025: 0.2%● unchanged vs 05-2025 07-2025: 0.3%▲ +0.1 percentage points vs 06-2025 08-2025: 0.3%● unchanged vs 07-2025 09-2025: 0.2%▼ -0.1 percentage points vs 08-2025 10-2025: 0.2%● unchanged vs 09-2025 11-2025: 0.2%● unchanged vs 10-2025 12-2025: 0.2%● unchanged vs 11-2025 01-2026: 0.2%● unchanged vs 12-2025 02-2026: 0.2%● unchanged vs 01-2026 03-2026: 0.2%● unchanged vs 02-2026 04-2026: 0.2%● unchanged vs 03-2026 05-2026: 0.2%● unchanged vs 04-2026lowest value 06-2026: 0.2%● unchanged vs 05-2026lowest value 07-2026: 0.2%● unchanged vs 06-2026 08-2026: 0.2%● unchanged vs 07-2026 09-2026: 0.2%● unchanged vs 08-2026 10-2026: 0.2%● unchanged vs 09-2026
Credit of up to €600,000 on 30-day terms is acceptable
Liquidity insufficient (current ratio 0.43, compared with 0.37 in 2025, below 1; short-term debt: 39.7% and cash: 5.3% of total assets), and 52.9% of the assets are financed with debt and provisions.
How it is calculated

The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 47, small): better than 69% on solvency, 41% on liquidity, 92% on profitability and 83% on growth.

The bankruptcy probability was computed on 31-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).

Credit check for your own amount and term

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

Five signals.
lowers riskraises riskneutral
raises risk · Liquidity: current ratio 0.43, cash €759,495
NBB · annual accounts
lowers risk · Founded in 2006
Companies that have existed this long fail less often; how much that weighs depends on the rest of its profile.
KBO
lowers risk · Profit of €1.9m (financial year 2026)
NBB · annual accounts
lowers risk · Equity €6.8m (47.1% of total assets)
NBB · annual accounts
neutral · Latest accounts filed on time
The financial year that closed on 31-03-2026 was due by 31-10-2026 and was filed on 26-08-2026, 66 days ahead of the deadline.
NBB · 10 filings
Deviation from the deadline
2026
66 days early
2025
88 days early
2024
28 days late
2023
4 days early
2022
11 days early
2021
2 days early
2020
2 days early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 7 accounts on average 21 days before the deadline; the sector median (NACE 47) for financial year 2024 is on the deadline day, and 47% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-03-2027 and is due by 31-10-2027. Nothing is late today. The company usually files around 20 October (4 of the last 5 filed years within 55 days of that day).
Companies Code · seven months
Where today falls in the filing period
01-11-2026 today31-03-2027 year end31-10-2027 deadline
neutral · No strike-offs in the KBO publications
Searched since 2021.
KBO publications · our coverage

Key points

  • Positive: Largest company by equity in Hamont-Achel, Wholesale and retail trade sectorin the Checked rankings No. 1 View
  • Positive: 8 profitable years in a rowprofit 2026: €1.9m 8 years View
  • Heads a groupcompanies controlled 4 View
  • Positive: Staff rose in 2026from 12.6 FTE to 16.7 FTE ▲ 32.5% View

Documents

Annual accounts at the NBB

All 20 annual accounts

Acts in the Belgian Official Gazette

All publications in the Belgian Official Gazette

Articles and registers

Key facts about Apotheek Hulsbosch

What is the company number of Apotheek Hulsbosch?
0879.969.548. In Belgium the VAT number is the company number with BE in front: BE 0879.969.548.
Where is Apotheek Hulsbosch based?
The registered office is at Michielsplein 15, 3930 Hamont-Achel.Company details
What does Apotheek Hulsbosch do?
According to the KBO register, the main activity is retail sale of pharmaceutical products (NACE 47730).
What is the legal form of Apotheek Hulsbosch?
Private limited company (BV).
When was Apotheek Hulsbosch founded?
On 14-03-2006.
Is Apotheek Hulsbosch still active?
Yes, Apotheek Hulsbosch is an active enterprise in the KBO register.
How many employees does Apotheek Hulsbosch have?
On average 16.7 full-time equivalents in financial year 2026, according to the filed annual accounts.Financials
What is the turnover of Apotheek Hulsbosch?
€11.6m in financial year 2026, according to the filed annual accounts.
Is Apotheek Hulsbosch profitable?
In financial year 2026, Apotheek Hulsbosch made a profit of €1.9m.
Where can I find the annual accounts of Apotheek Hulsbosch?
Apotheek Hulsbosch filed 20 annual accounts with the National Bank of Belgium, the latest for financial year 2026.Annual accounts at the National Bank
When are the next annual accounts of Apotheek Hulsbosch due?
By 31-10-2027, for financial year 2027.Timeline

Companies related to Apotheek Hulsbosch

Go further with this company

How much credit can you give this customer, and on what payment terms?Credit check What should you check before you do business with this company?Supplier due diligence Is the workforce growing, and do people stay?Employer check Can you accept this company as a client under the anti-money-laundering law?AML client file Which of your other customers can you e-invoice via Peppol?Peppol check What support did similar companies receive that this one did not?Subsidies

Your own company? See how customers, suppliers and banks see it and what to improve first.

Investigating this company? Keep it with today's facts in a case file.

We would like to set cookies. That happens only with your consent. What we measure